XML 15 R5.htm IDEA: XBRL DOCUMENT v3.24.3
Consolidated Balance Sheet - USD ($)
$ in Millions
Sep. 30, 2024
Dec. 31, 2023
Current assets:    
Cash and cash equivalents $ 762 $ 2,150
Receivables, Net, Current 1,310 1,655
Inventories 275 274
Derivative assets 143 239
Other current assets and deferred charges 208 195
Total current assets 2,698 4,513
Investments 4,201 4,637
Property, Plant and Equipment, Gross 56,479 51,842
Accumulated depreciation and amortization (18,505) (17,531)
Property, plant, and equipment - net 37,974 34,311
Intangible assets – net of accumulated amortization 7,305 7,593
Regulatory assets, deferred charges, and other 1,659 1,573
Total assets 53,837 52,627
Current liabilities:    
Accounts payable 1,137 1,379
Derivative Liability, Current 95 105
Accrued and other current liabilities 1,203 1,284
Commercial Paper 0 725
Long-term debt due within one year 2,284 2,337
Total current liabilities 4,719 5,830
Long-term debt 24,825 23,376
Deferred income tax liabilities 4,312 3,846
Regulatory liabilities, deferred income, and other 5,116 4,684
Contingent liabilities and commitments (Note 9)
Stockholders’ equity:    
Preferred stock ($1 par value; 30 million shares authorized at September 30, 2024 and December 31, 2023; 35 thousand shares issued at September 30, 2024 and December 31, 2023) 35 35
Common stock ($1 par value; 1,470 million shares authorized at September 30, 2024 and December 31, 2023; 1,258 million shares issued at September 30, 2024 and 1,256 million shares issued at December 31, 2023) 1,258 1,256
Capital in excess of par value 24,611 24,578
Retained deficit (12,296) (12,287)
Accumulated other comprehensive income (loss) 0 0
Treasury stock, at cost (39 million shares at September 30, 2024 and December 31, 2023 of common stock) (1,180) (1,180)
Total stockholders’ equity 12,428 12,402
Noncontrolling interests in consolidated subsidiaries 2,437 2,489
Total equity 14,865 14,891
Total liabilities and equity $ 53,837 $ 52,627